These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Beta-blockers and coronary insufficiency. Which drug do we choose? How do we evaluate their efficacy? When do we avoid them?]. Weber S; Degeorges M Sem Hop; 1980 Oct 18-25; 56(39-40):1595-8. PubMed ID: 6108613 [No Abstract] [Full Text] [Related]
28. [Capillary hyperlactacidemia, criterion of exertion intolerance in patients treated with beta-blockaders]. Haissly JC; Junod A; Curati W; Robert M; Rossel CF Schweiz Med Wochenschr; 1974 Nov; 104(44):1592-3. PubMed ID: 4153818 [No Abstract] [Full Text] [Related]
29. [Possibilities of the therapy of hypertension with beta blockaders]. Tuckman J; Flury W Schweiz Rundsch Med Prax; 1972 Sep; 61(36):1107-9. PubMed ID: 4156940 [No Abstract] [Full Text] [Related]
30. [Digitalis and coronary heart disease (author's transl)]. Schüren KP; Kötter V; Schröder R Z Kardiol; 1980 May; 69(5):319-28. PubMed ID: 6109408 [No Abstract] [Full Text] [Related]
31. [Effect of beta-blockaders on coronary output: study in humans using xenon- 133 ]. Lichtlen P; Albert H; Moccetti T Therapie; 1970; 25(2):403-8. PubMed ID: 4403160 [No Abstract] [Full Text] [Related]
32. [Intrinsic sympathomimetic activity with beta-receptor blockers. Significance for differential therapy (author's transl)]. Noack E MMW Munch Med Wochenschr; 1982 Apr; 124(15):377-80. PubMed ID: 6123078 [No Abstract] [Full Text] [Related]
33. [Effects of nitroglycerin on exercise hemodynamics in patients with coronary heart disease under treatment with beta-blockers (mepindolol, oxprenolol) and a calcium-antagonist (fendiline) (author's transl)]. Reiterer W Wien Med Wochenschr; 1980 Dec; 130(23):772-7. PubMed ID: 6111161 [TBL] [Abstract][Full Text] [Related]
34. [Various beta-receptor blockaders affect hemodynamics in different ways]. Guobrandsson T; Hansson L; Sivertsson R; Svensson A Lakartidningen; 1982 Oct; 79(43):3908-10. PubMed ID: 6130194 [No Abstract] [Full Text] [Related]
35. The role of beta-blockade for prevention/therapeutic intervention in subjects with coronary prone behaviour pattern. Taggart P Act Nerv Super (Praha); 1982; Suppl 3(Pt 2):529-30. PubMed ID: 6134421 [No Abstract] [Full Text] [Related]
36. [Nurses' drug information. Therapeutic main group: beta receptor blockaders. Their use in cardiology. 2]. Lumholtz IB Sygeplejersken; 1975 May; 75(18):13. PubMed ID: 237333 [No Abstract] [Full Text] [Related]
37. [Nurse's drug information. Therapeutic main group: beta receptor blockaders. Their use in cardiology. 3]. Lumholtz IB Sygeplejersken; 1975 May; 75(20):11. PubMed ID: 237335 [No Abstract] [Full Text] [Related]
38. [Centra, peripheral, and volumetric hemodynamic changes in the treatment of essential hypertension with calcium antagonists and beta blockaders]. Mattioli G; Ricci S; Teglio V Minerva Cardioangiol; 1980 May; 28(5):295-302. PubMed ID: 6111047 [No Abstract] [Full Text] [Related]
39. [The patient with heart disease and therapy with beta blockers. Results of an international TV-symposium in Stockholm]. Fortschr Med; 1980 Oct; 98(37):1437-40. PubMed ID: 6107267 [No Abstract] [Full Text] [Related]
40. [Therapy with beta-blocking agents in cardiology]. Dal Palù C Minerva Med; 1970 Nov; 61(95):5450-8. PubMed ID: 4395227 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]